Douglas F. Nixon, MD, PhD

Chair / Scientific Advisory Board & Professor / Weill Cornell Medicine

Weill Cornell Medicine 413 East 69th Street New York, NY 10021

A scientist and educator, Douglas F. Nixon has actively pursued immunovirology research for more than 28 years, with his studies spanning from clinical research and human immunology, to basic virology, vaccine development and molecular biology.


Among his accomplishments, Nixon has gained recognition for publishing the first identification of an HIV specific cytotoxic T cell (CTL) epitope. He has published more than 250 articles in peer-reviewed journals, including first-or-senior author publications in Nature, PNAS, Journal of Clinical Investigation, PLoS Pathogens, and he holds several patents. In recognition of several important contributions to HIV/AIDS research, he was awarded the Elisabeth Glaser Scientist Award in 2000.

That same year, he joined the Gladstone Institute of Virology and Immunology in San Francisco as an Associate Professor. In 2006, he accepted the appointment of Professor of Medicine at the University of California, San Francisco (UCSF) as Associate Chief of the Division of Experimental Medicine. From 2013 – 2018, he was recruited to the George Washington University as Chair and Walter G. Ross Professor of the Department of Microbiology, Immunology and Tropical Medicine. In 2018, he was appointed Professor of Immunology in Medicine at the Weill Cornell Medical College in New York City.

Training and Education

  • 1992
    DPhil, Oxford University
  • 1991
    MA, Oxford University
  • 1984
    MB/BS, Imperial College London
  • 1981
    BSc, University College London